Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Postmortem examination was performed on 137 residents (average age 85.5 years) of a skilled nursing facility whose mental status, memory, and functional status had been evaluated during life. Seventy‐eight percent were demented using conservative criteria; 55% had characteristic Alzheimer's disease. Choline acetyltransferase and somatostatin were significantly reduced in the brains of patients with Alzheimer's disease as compared with age‐matched nursing home control subjects, although the degree of the reduction was less severe than found in subjects less than 80 years of age. Ten subjects whose functional and cognitive performance was in the upper quintile of the nursing home residents, as good as or better than the performance of the upper quintile of residents without brain pathology (control subjects), showed the pathological features of mild Alzheimer's disease, with many neocortical plques. Plaque counts were 80% of those of demented patients with Alzheimer's disease. Choline acetyltransferase and somatostatin levels were intermediate between controls and demented patients with Alzheimer's disease. The unexpected findings in these subjects were higher brain weights and greater number of neurons (> 90μm 2 in a cross‐sectional area in cerebral cortex) as compared to age‐matched nursing home control subjects. These people may have had incipient Alzheimer's disease but escaped loss of large neurons, or alternatively, started with larger brains and more large neurons and thus might be said to have had a greater reserve.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This idea is supported by a set of studies that suggest that prevalence or incidence of dementia is lower in individuals with larger brains13, 14.”
From Cognitive reserve in ageing and Alzheimer's disease (2012) · cites this paper as [13]
In the citing paper
“Aβ alone is not predictive of AD”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [146]
In the citing paper
“many older neuropsychologically healthy individuals display amyloid deposition (145, 146)”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [146]
In the citing paper
“Senile plaques (SPs) and neurofibrillary tangles (NFTs), the neuropathological hallmarks of Alzheimer’s disease (AD),(Khachaturian, 1985) are not limited to individuals with dementia of the Alzheimer type (DAT) but also may be present in the brains of cognitively normal older adults.(Tomlinson et al., 1968; Crystal et al., 1988; Katzman et al., 1988; Price et al., 1991; Dickson et al., 1992; Tronc”
From Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease (2009) · cites this paper as Katzman et al., 1988
In the citing paper
“Decades of clinical-pathological correlative studies, now corroborated by a decade of neuroimaging studies, also demonstrate a sizable percentage of the non-demented elderly have plaques [40, 51, 54, 55, 58–68].”
From Brain aging, Alzheimer's disease, and mitochondria (2011) · cites this paper as [61]
Citations
Cites
Blessed, G., Tomlinson, B. E., & Roth, M. (1968) · British Journal of Psychiatry · doi:10.1192/bjp.114.512.797 · Cited by 4,117
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565
Self-citationDiagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Validation of a short Orientation-Memory-Concentration Test of cognitive impairment
(1983) · American Journal of Psychiatry · doi:10.1176/ajp.140.6.734 · Cited by 2,117
Self-citationObservations on the brains of demented old people
Tomlinson, B. E., Blessed, G., & Roth, M. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90063-8 · Cited by 2,084
Perry, E. K., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P. H., & Perry, R. H. (1978) · BMJ · doi:10.1136/bmj.2.6150.1457 · Cited by 2,042
Asher, R. (1961) · The Lancet · doi:10.1016/s0140-6736(61)91217-x · Cited by 1,290
Fonnum, F. (1969) · Biochemical Journal · doi:10.1042/bj1150465 · Cited by 1,035
Davies, P., Katzman, R., & Terry, R. D. (1980) · Nature · doi:10.1038/288279a0 · Cited by 882
Self-citationAlzheimer's Disease: Senile Dementia and Related Disorders
Bellur, S. N. (1979) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1979.03300200059031 · Cited by 803
Research works printed but not linked: 2
- American Psychiatric Association Task Force on Nomenclature and Statistics, 1980, Diagnostic and Statistical Manual of Mental Disorders (DSM‐III), 124
- BrownT RenbingX KatzmanR FuldP:Measuring the stability of a test in a dementing population. Alz Dis Assoc Disord (in press)
Cited by
Cognitive reserve in ageing and Alzheimer's disease
Stern, Y. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70191-6 · Cited by 3,557
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
“β-amyloid(1-40) effects on behavior and memory.”
BackgroundInfluentialSoluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
Unfolding the role of protein misfolding in neurodegenerative diseases
Soto, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1007 · Cited by 1,506
“Soluble multimeric Alzheimer β(1-40) preamyloid complexes in dilute solution.”
BackgroundHertzog, C., Kramer, A. F., Wilson, R. S., & Lindenberger, U. (2008) · Psychological Science in the Public Interest · doi:10.1111/j.1539-6053.2009.01034.x · Cited by 1,495
“A third rival hypothesis is that mentally stimulating activity is associated with features of brain structure or function that somehow reduce the deleterious effects of common age-related neuropathology (Katzman et al., 1988; Satz, 1993; Stern, 2002; Wilson & Bennett, 2003).”
BackgroundInfluential
Metadata
- Authors
- Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A.
- Affiliations
- University of California San Diego (US)
- Queens College, CUNY (US)
- New Jewish Home (US)
- Albert Einstein College of Medicine (US)
- Corresponding author
- Katzman, Robert
- ORCID
- Davies, Peter
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1988-02
- Volume
- 23
- Issue
- 2
- Pages
- 138-144
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2072371192
- Cited by
- 1,225
- References
- 20
- Citations by year
- 2026: 19 · 2025: 35 · 2024: 37 · 2023: 50 · 2022: 46 · 2021: 43 · 2020: 68 · 2019: 37 · 2018: 47 · 2017: 45 · 2016: 49 · 2015: 32 · 2014: 35 · 2013: 44 · 2012: 38
- FWCI
- 22.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ag005386-03)
- National Institute on Aging (P50AG005131, AG P01-5386, P50-AG05131)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, dementia, choline acetyltransferase, somatostatin, brain reserve, neuron size, brain weight, nursing home residents, neurochemical changes
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain Chemistry, Cerebral Cortex, Choline O-Acetyltransferase, Dementia, Female, Humans, Male, Neurofibrils, Prospective Studies, Somatostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. https://app.cochat.ai/papers/10.1002/ana.410230206
- The paper
- Katzman, R., Terry, R., DeTeresa, R., Brown, T., Davies, P., Fuld, P., Renbing, X., & Peck, A. (1988). Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Annals of Neurology. https://doi.org/10.1002/ana.410230206
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.